Dasatinib, Temsirolimus, and Cyclophosphamide in Treating Patients With Advanced, Recurrent, or Refractory Solid Tumors
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
Columbia University
City of Hope Medical Center
UNC Lineberger Comprehensive Cancer Center
University of Southern California
M.D. Anderson Cancer Center
Emory University
The University of Texas Health Science Center at San Antonio